loading

Proqr Therapeutics N V Aktie (PRQR) Neueste Nachrichten

pulisher
05:28 AM

ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

05:28 AM
pulisher
03:58 AM

Is ProQR Therapeutics N.V. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia

03:58 AM
pulisher
Jul 24, 2025

Is ProQR Therapeutics N.V. stock a growth or value playVerified Return Tips - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

Will ProQR Therapeutics N.V. stock benefit from interest rate changesAccelerated financial growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives ProQR Therapeutics N.V. stock priceStrong return on assets - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about ProQR Therapeutics N.V. stockUnprecedented profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 21, 2025

Owning 32% shares,institutional owners seem interested in ProQR Therapeutics N.V. (NASDAQ:PRQR), - Yahoo Finance

Jul 21, 2025
pulisher
Jul 19, 2025

ProQR Therapeutics N.V. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 17, 2025

ProQR stock rating reiterated by Cantor Fitzgerald ahead of key 2H25 data - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 15, 2025

Why ProQR Therapeutics N.V. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ProQR Therapeutics N.V. stock performs during market volatilityProven Win Setups - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes ProQR Therapeutics N.V. stock price move sharplyFree Wealth-Building Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) high institutional ownership speaks for itself as stock continues to impress, up 16% over last week - simplywall.st

Jul 15, 2025
pulisher
Jul 14, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Shares Acquired by OneDigital Investment Advisors LLC - Defense World

Jul 14, 2025
pulisher
Jul 11, 2025

ProQR Therapeutics (NASDAQ:PRQR) Stock Price Crosses Above Fifty Day Moving AverageWhat's Next? - MarketBeat

Jul 11, 2025
pulisher
Jul 10, 2025

Vontobel Holding Ltd. Invests $48,000 in ProQR Therapeutics N.V. (NASDAQ:PRQR) - Defense World

Jul 10, 2025
pulisher
Jul 07, 2025

ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces clinical hurdles - Investing.com Australia

Jul 07, 2025
pulisher
Jul 06, 2025

ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces clinical hurdles By Investing.com - Investing.com South Africa

Jul 06, 2025
pulisher
Jul 03, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Rating of "Buy" by Analysts - MarketBeat

Jul 03, 2025
pulisher
Jun 30, 2025

ProQR Therapeutics' (PRQR) "Market Outperform" Rating Reaffirmed at JMP Securities - MarketBeat

Jun 30, 2025
pulisher
Jun 28, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Market Outperform Rating at JMP Securities - Defense World

Jun 28, 2025
pulisher
Jun 27, 2025

PRQR: Cantor Fitzgerald Reiterates Overweight Rating | PRQR Stoc - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

ProQR stock advances as Cantor Fitzgerald reaffirms $8 price target By Investing.com - Investing.com Canada

Jun 27, 2025
pulisher
Jun 27, 2025

ProQR stock advances as Cantor Fitzgerald reaffirms $8 price target - Investing.com

Jun 27, 2025
pulisher
Jun 26, 2025

ProQR submits clinical trial application for RNA editing therapy By Investing.com - Investing.com India

Jun 26, 2025
pulisher
Jun 26, 2025

ProQR Seeks EU Approval for Liver Cell Protein Trial - MarketScreener

Jun 26, 2025
pulisher
Jun 26, 2025

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP - GlobeNewswire

Jun 26, 2025
pulisher
Jun 26, 2025

ProQR Advances First RNA Editing Therapy to Clinical Trials for Liver Disease | PRQR Stock News - Stock Titan

Jun 26, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Boosts Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected - simplywall.st

Jun 13, 2025
pulisher
Jun 13, 2025

Equities Analysts Offer Predictions for PRQR FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 11, 2025

Research Analysts Set Expectations for PRQR FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Buys Shares of 11,400 ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Analysts Set ProQR Therapeutics (NASDAQ:PRQR) Target Price at $8.00 - MarketBeat

Jun 09, 2025
pulisher
Jun 09, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Grows Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Buys 320,614 Shares of ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 06, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):